Log in to save to my catalogue

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvan...

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2785199254

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

About this item

Full title

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

Publisher

New York: Springer US

Journal title

Breast cancer research and treatment, 2023-05, Vol.199 (1), p.81-89

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
Neoadjuvant systemic therapy (NST) is increasingly used in breast cancer patients and depending on subtype, 10–89% of patients will attain pathologic complete response (pCR). In patients with pCR, risk of local recurrence (LR) after breast conserving therapy is low. Although adjuvant radiotherapy after breast conserving surgery (BCS) red...

Alternative Titles

Full title

De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2785199254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2785199254

Other Identifiers

ISSN

0167-6806

E-ISSN

1573-7217

DOI

10.1007/s10549-023-06899-y

How to access this item